Laurence M. Corash - 13 Dec 2021 Form 4 Insider Report for CERUS CORP (CERS)

Role
Chief Scientific Officer
Signature
Laurence M. Corash by Chrystal Menard, attorney-in-fact
Issuer symbol
CERS
Transactions as of
13 Dec 2021
Net transactions value
+$150,000
Form type
4
Filing time
15 Dec 2021, 19:57:58 UTC
Next filing
21 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERS Common Stock Options Exercise $150,000 +40,000 +2% $3.75 2,022,586 13 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERS Option (Right to Buy) Options Exercise -40,000 -89% 5,000 13 Dec 2021 Common Stock 40,000 $3.75 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter.
F2 Not applicable.